- Home
- LEGN vs RGC Comparison
LEGN vs RGC Comparison
Compare LEGN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- RGC
- Stock Information
- Founded
- LEGN 2014
- RGC 2014
- Country
- LEGN United States
- RGC Hong Kong
- Employees
- LEGN N/A
- RGC N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- LEGN Health Care
- RGC Health Care
- Exchange
- LEGN Nasdaq
- RGC Nasdaq
- Market Cap
- LEGN 6.7B
- RGC 6.6B
- IPO Year
- LEGN 2020
- RGC 2021
- Fundamental
- Price
- LEGN $34.47
- RGC $15.60
- Analyst Decision
- LEGN Strong Buy
- RGC
- Analyst Count
- LEGN 12
- RGC 0
- Target Price
- LEGN $73.36
- RGC N/A
- AVG Volume (30 Days)
- LEGN 1.1M
- RGC 283.3K
- Earning Date
- LEGN 11-11-2025
- RGC 10-24-2025
- Dividend Yield
- LEGN N/A
- RGC N/A
- EPS Growth
- LEGN N/A
- RGC N/A
- EPS
- LEGN N/A
- RGC N/A
- Revenue
- LEGN $796,838,000.00
- RGC N/A
- Revenue This Year
- LEGN $70.75
- RGC N/A
- Revenue Next Year
- LEGN $52.47
- RGC N/A
- P/E Ratio
- LEGN N/A
- RGC N/A
- Revenue Growth
- LEGN 74.75
- RGC N/A
- 52 Week Low
- LEGN $27.34
- RGC $0.09
- 52 Week High
- LEGN $52.15
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- LEGN 44.92
- RGC 58.48
- Support Level
- LEGN $32.70
- RGC $14.08
- Resistance Level
- LEGN $34.71
- RGC $15.25
- Average True Range (ATR)
- LEGN 1.21
- RGC 1.12
- MACD
- LEGN 0.07
- RGC 0.29
- Stochastic Oscillator
- LEGN 46.90
- RGC 76.70
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.